QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol

John C. Somberg, Richard A Preston, Vasant Ranade, Janos Molnar

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objectives: The aim of this study was to evaluate the correlation between QT interval (QT) and serum sotalol concentration following a single low dose of oral and intravenous sotalol. Methods: Fifteen healthy volunteers received 75 mg intravenous sotalol over 2.5 h and 80 mg oral sotalol in a random order. Serum sotalol concentrations and 12-lead electrocardiograms were obtained simultaneously at baseline and 7 times following dosings. Rate-corrected QT (QTc) was calculated by the Bazett, Fridericia and Framingham formulas. Linear regression analysis was performed between sotalol concentrations and QT measurements. Results: Significant QT prolongation was seen at very low sotalol doses and serum concentrations. QTc intervals calculated by the Framingham and Fridericia formulas showed the strongest and virtually identical correlations with serum sotalol concentration (r ≥ 0.97, p < 0.001) following oral and intravenous administrations. The equation QTc = 0.0342 (sotalol concentration) + 398 closely predicted actual QTc at any sotalol concentration. Conclusions: A strong correlation was observed between serum sotalol concentration and QTc prolongation across the entire concentration range. Low-dose sotalol caused significant QT prolongation. At similar concentrations, intravenous and oral sotalol caused similar QT and QTc effects. Knowing the QT effect can be used to guide further dose increase.

Original languageEnglish
Pages (from-to)219-225
Number of pages7
JournalCardiology
Volume116
Issue number3
DOIs
StatePublished - Aug 1 2010

Fingerprint

Sotalol
Serum
Intravenous Administration
Oral Administration

Keywords

  • Pharmacodynamics
  • QT prolongation
  • Sotalol
  • Torsade de pointes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Cite this

QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. / Somberg, John C.; Preston, Richard A; Ranade, Vasant; Molnar, Janos.

In: Cardiology, Vol. 116, No. 3, 01.08.2010, p. 219-225.

Research output: Contribution to journalArticle

Somberg, John C. ; Preston, Richard A ; Ranade, Vasant ; Molnar, Janos. / QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. In: Cardiology. 2010 ; Vol. 116, No. 3. pp. 219-225.
@article{1752374868474547bd6b17966470766a,
title = "QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol",
abstract = "Objectives: The aim of this study was to evaluate the correlation between QT interval (QT) and serum sotalol concentration following a single low dose of oral and intravenous sotalol. Methods: Fifteen healthy volunteers received 75 mg intravenous sotalol over 2.5 h and 80 mg oral sotalol in a random order. Serum sotalol concentrations and 12-lead electrocardiograms were obtained simultaneously at baseline and 7 times following dosings. Rate-corrected QT (QTc) was calculated by the Bazett, Fridericia and Framingham formulas. Linear regression analysis was performed between sotalol concentrations and QT measurements. Results: Significant QT prolongation was seen at very low sotalol doses and serum concentrations. QTc intervals calculated by the Framingham and Fridericia formulas showed the strongest and virtually identical correlations with serum sotalol concentration (r ≥ 0.97, p < 0.001) following oral and intravenous administrations. The equation QTc = 0.0342 (sotalol concentration) + 398 closely predicted actual QTc at any sotalol concentration. Conclusions: A strong correlation was observed between serum sotalol concentration and QTc prolongation across the entire concentration range. Low-dose sotalol caused significant QT prolongation. At similar concentrations, intravenous and oral sotalol caused similar QT and QTc effects. Knowing the QT effect can be used to guide further dose increase.",
keywords = "Pharmacodynamics, QT prolongation, Sotalol, Torsade de pointes",
author = "Somberg, {John C.} and Preston, {Richard A} and Vasant Ranade and Janos Molnar",
year = "2010",
month = "8",
day = "1",
doi = "10.1159/000316050",
language = "English",
volume = "116",
pages = "219--225",
journal = "Cardiology (Switzerland)",
issn = "0008-6312",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol

AU - Somberg, John C.

AU - Preston, Richard A

AU - Ranade, Vasant

AU - Molnar, Janos

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Objectives: The aim of this study was to evaluate the correlation between QT interval (QT) and serum sotalol concentration following a single low dose of oral and intravenous sotalol. Methods: Fifteen healthy volunteers received 75 mg intravenous sotalol over 2.5 h and 80 mg oral sotalol in a random order. Serum sotalol concentrations and 12-lead electrocardiograms were obtained simultaneously at baseline and 7 times following dosings. Rate-corrected QT (QTc) was calculated by the Bazett, Fridericia and Framingham formulas. Linear regression analysis was performed between sotalol concentrations and QT measurements. Results: Significant QT prolongation was seen at very low sotalol doses and serum concentrations. QTc intervals calculated by the Framingham and Fridericia formulas showed the strongest and virtually identical correlations with serum sotalol concentration (r ≥ 0.97, p < 0.001) following oral and intravenous administrations. The equation QTc = 0.0342 (sotalol concentration) + 398 closely predicted actual QTc at any sotalol concentration. Conclusions: A strong correlation was observed between serum sotalol concentration and QTc prolongation across the entire concentration range. Low-dose sotalol caused significant QT prolongation. At similar concentrations, intravenous and oral sotalol caused similar QT and QTc effects. Knowing the QT effect can be used to guide further dose increase.

AB - Objectives: The aim of this study was to evaluate the correlation between QT interval (QT) and serum sotalol concentration following a single low dose of oral and intravenous sotalol. Methods: Fifteen healthy volunteers received 75 mg intravenous sotalol over 2.5 h and 80 mg oral sotalol in a random order. Serum sotalol concentrations and 12-lead electrocardiograms were obtained simultaneously at baseline and 7 times following dosings. Rate-corrected QT (QTc) was calculated by the Bazett, Fridericia and Framingham formulas. Linear regression analysis was performed between sotalol concentrations and QT measurements. Results: Significant QT prolongation was seen at very low sotalol doses and serum concentrations. QTc intervals calculated by the Framingham and Fridericia formulas showed the strongest and virtually identical correlations with serum sotalol concentration (r ≥ 0.97, p < 0.001) following oral and intravenous administrations. The equation QTc = 0.0342 (sotalol concentration) + 398 closely predicted actual QTc at any sotalol concentration. Conclusions: A strong correlation was observed between serum sotalol concentration and QTc prolongation across the entire concentration range. Low-dose sotalol caused significant QT prolongation. At similar concentrations, intravenous and oral sotalol caused similar QT and QTc effects. Knowing the QT effect can be used to guide further dose increase.

KW - Pharmacodynamics

KW - QT prolongation

KW - Sotalol

KW - Torsade de pointes

UR - http://www.scopus.com/inward/record.url?scp=77955204520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955204520&partnerID=8YFLogxK

U2 - 10.1159/000316050

DO - 10.1159/000316050

M3 - Article

C2 - 20693799

AN - SCOPUS:77955204520

VL - 116

SP - 219

EP - 225

JO - Cardiology (Switzerland)

JF - Cardiology (Switzerland)

SN - 0008-6312

IS - 3

ER -